Supplements
garlic decreases gastric cancer risk
In plain terms: Does garlic prevent cancer?
Part of: 🧪 Garlic
The strongest evidence says no. Weaker studies (case-control) suggest garlic-eaters get less stomach cancer, but that benefit vanishes in higher-quality cohort studies, and the one long-term trial found garlic did nothing — only treating the H. pylori bacteria helped. The apparent link looks like study bias.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
The popular 'garlic prevents cancer' idea is not supported by the strongest evidence. Case-control studies show a protective association, but it collapses to null in prospective cohort studies, and the one long-term RCT (the Shandong Intervention Trial) found garlic did NOT significantly reduce gastric cancer — only H. pylori antibiotic treatment did.
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Yi X et al 2025 · study_type: observational | observational | supports | low | Narrative review of preclinical and clinical studies on garlic organosulfur compounds and gastric cancer states that 'regular garlic consumption may reduce the risk of gastric cancer and improve outcomes in patients undergoing chemotherapy, |
| Fleischauer AT et al. 2000 · Am J Clin Nutr | observational | supports | moderate | Landmark meta: colorectal RR 0.69, stomach 0.53 - but authors flag heterogeneity, publication bias (p=.049), confounding by total vegetables. |
| Kodali RT, Eslick GD 2015 · Nutr Cancer | meta-analysis | supports | moderate | Meta (mostly case-control; 8,621 cases): high garlic intake OR 0.49 for gastric cancer - but the pooled effect is case-control-driven. |
| Wu J et al 2025 · study_type: observational | observational | contradicts | moderate | Case-control study of 10,035 people in Gansu, China (7,058 analyzed, 4,712 with atrophic gastritis) found garlic intake was a significant RISK factor for atrophic gastritis in H. pylori-infected/eradicated participants (OR=1.39, 95% CI 1.06 |
| Li WQ et al. 2018 · Helicobacter | meta-analysis | contradicts | moderate | Meta 18 studies (142,921): OR 0.51 overall BUT NULL when restricted to prospective cohorts (OR 0.95) - the protective signal is case-control bias. |
| Ma JL et al. 2012 · J Natl Cancer Inst | RCT | contradicts | high | Shandong Intervention Trial, 14.7-yr RCT (n=3,365): 7.3 yr garlic supplementation did NOT significantly reduce gastric cancer; only H. pylori antibiotic treatment did. |
| Zhu B et al. 2014 · Clin Gastroenterol Hepatol | observational | contradicts | high | Meta prospective cohorts ONLY: colorectal RR 1.06 (null); garlic SUPPLEMENTS RR 1.18 (increased risk) - protective signal reverses in cohorts. |
| Wang Z et al 2025 · study_type: observational | observational | supports | low | Mendelian randomization using SNPs associated with garlic/onion intake as instrumental variables found a negative causal association between garlic and gastric cancer risk (IVW OR=0.70, 95% CI 0.49-0.99, P=.046); onion showed no association |
| Hu JY et al. 2014 · World J Gastroenterol | observational | tested-null | high | Meta prospective cohorts only: colorectal garlic RR 1.06 (null); supplements 1.12 (ns) - confirms cohort null. |
| Chiavarini M et al. 2016 · Public Health Nutr | observational | tested-null | high | Meta: colorectal pooled OR 0.93 (ns); case-control 0.63 (protective) vs cohort null - textbook design split. |
| Wang Y et al. 2022 · Oncol Lett | meta-analysis | supports | low | Observational meta/review: garlic associated with lower gastric (OR 0.65) and colorectal (OR 0.75) cancer; all observational, mechanism-heavy. |
| Wan Q et al. 2019 · Food Sci Nutr | meta-analysis | supports | low | Umbrella review: allium/garlic intake associated with lower gastric cancer (RR 0.78) - pooled observational meta-analyses of varying quality. |
| Zhang N et al. 2022 · Iran J Public Health | observational | tested-null | low | Meta 17 studies: breast cancer garlic RR 0.77 (case-control-heavy; authors call for prospective studies). |
| Wang M et al 2025 · study_type: observational | RCT | mixed | low | Multistage metabolomic/Mendelian randomization study using the Shandong Intervention Trial (SIT) and MITS cohorts found plasma L-aspartic acid predicts gastric cancer risk and modifies primary-prevention effects; the beneficial effect of ga |
| Guercio V et al. 2015 · Mol Nutr Food Res | observational | supports | moderate | Meta: upper-aerodigestive-tract cancer garlic RR 0.74 (case-control); relation 'unclear in cohorts'. |
| Turati F et al. 2014 · Mol Nutr Food Res | meta-analysis | tested-null | moderate | Meta 16 observational (colorectal): borderline RR 0.85 overall, but cohort-only subgroup NULL (0.99) vs case-control 0.76. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.